Anti-hepatitis B transfer factor for injection

Anti-HBV transfer factor can transmit specific cellular immune information of hepatitis B, and has the function of regulating and enhancing the body's specific cellular immunity against hepatitis B virus infection. When it enters the human body, it can transform the patient's normal T cells into specific sensitized T cells. Sensitized T cells are divided into two types: killer sensitized T cells (TC) and delayed-type hypersensitivity T cells (TDTH). Killer sensitized T cells (TC) can specifically kill liver cells parasitized by hepatitis B virus and drive hepatitis B virus out of the liver cells where it parasitizes; delayed-type hypersensitivity T cells (TDTH) can release a variety of lymphokines, such as interferon, interleukin, transfer factor, phagocyte activation factor, etc., to mediate inflammatory response and enhance the killing of viruses. At the same time, the released lymphokines can sensitize other lymphocytes in the body, form more effector lymphocytes, enhance and expand the cellular immune effect, thereby achieving the purpose of regulating the specific immune function of the human body and inhibiting the proliferation of hepatitis B virus. In addition, anti-hepatitis B transfer factor also has the components and functions of ordinary transfer factors, and can regulate other aspects of the body's immune function. This product has been confirmed by animal acute toxicity and long-term toxicity tests to have no toxic side effects and is a safe biological preparation.

Anti-hepatitis B transfer factor.

This product is white or slightly yellow loose body.

Used for patients with chronic hepatitis B who are HBeAg and HBV-DNA positive.

Each vial of this product is dissolved in 2 ml of injection water and injected intramuscularly. A course of treatment is 12 weeks. From the 1st to the 4th week, inject 2 mg once a day; from the 5th to the 12th week, inject 2 mg every 2 days. (2 to 4 mg each time, once a day or every other day).

No serious adverse reactions have been observed. If you have an allergic reaction, please treat it as an allergy.

It is contraindicated for patients who are allergic to this product or have liver, kidney or hematopoietic failure.

Not yet clear.

Keep sealed.

2mg peptide/vial

Wuhan Hiteck Biological Pharma Co., Ltd.

• Founded in:

  1992-04-08

• Address:

  Wuhan Economic and Technological Development Zone Haite Technology Park

• Tax NO.:

  91420100724667038L

• Registered Funds:

  130.894391 yuan

• Website:

  Log in to view

• Email:

  Log in to view